Healthcare
professionals have been keenly interested in the treatment of
gastroesophageal reflux disease (GERD) and stomach & intestinal
ulcer owing to its increasing prevalence. GERD is common health
problem, which leads to serious medical complications and further
huge medical expense in its diagnosis and treatment. The two most
frequently observed symptoms associated with GERD are heartburn and
acid regurgitation. Usually, over-the-counter antacids, proton pump
inhibitor, and H-2 receptor blockers are used to decrease the effects
of stomach acids or to block acid production.
Ranitidine
is a histamine H2 antagonists and available as both over-the-counter
(OTC) and prescription drug, indicated in the treatment of
gastroesophageal reflux disease (GERD). Ranitidine decreases the acid
production from stomach for up to 12 hours. Also, ranitidine is
commonly used in erosive esophagitis, peptide ulcer disease, and
Zollinger–Ellison syndrome. It could be taken orally or
intravenously.
To
Access the Free Sample Report:
https://www.coherentmarketinsights.com/insight/request-sample/2131
The
global ranitidine market size was valued at US$ 412.4 Mn in 2017, and
is expected to witness a CAGR of 1.8% over the forecast period (2018
– 2026).
Growing
Research and Development (R&D) on Ranitidine is expected to Boost
Market Growth
Various
government and private research organizations are increasingly
engaged in research and development studies to increase the efficacy
of ranitidine and examine possible potential of ranitidine to
increase future scope of ranitidine market.
Furthermore,
various clinical trials are currently undergoing to identify and
compare efficacy between ranitidine and other proton pump inhibitors
such as esomeprazole and rabeprazole to measure gastric acid
reduction in stomach. With the result of these studies, the efficacy
of ranitidine is expected to improve and offer better treatment
regimes in reducing excessive gastric acid production in the near
future.
Rising
Cases of Various Gastric Ulcers and Digestive Diseases is expected to
Increase Growth of the market
High
prevalence of gastroesophageal reflux disease (GERD), intestinal &
stomach ulcers, esophagitis, heartburn, and other digestive diseases
due to unhealthy lifestyle, changing dietary patterns will lead to
increase in demand for ranitidine-based medications in the near
future. According to Florida Hospital, 2018 U.S. data statistics, in
the U.S. over 60 million adults suffer from acid reflux symptoms
every month. Furthermore, the source states that each day an
estimated 25 million of the 60 million adults suffers from acid
reflux symptoms. Also, according to the same source, about 20% of
people with acid reflux will develop gastroesophageal reflux disease
(GERD) in the near future.
Heartburn
with or without regurgitation is identified as one of the prime
symptoms of gastroesophageal reflux disease (GERD). According to
World Gastroenterology Organization (WGO), 2015, prevalence of GERD
is rapidly increasing worldwide, with differences reported in
prevalence ranging from 2.5% to 6.6% in Eastern Asia while slightly
higher up to 13.8% to 25.8% in North America.
Get
Full Access of This Business Report:
https://www.coherentmarketinsights.com/market-insight/ranitidine-market-2131
Key
players operating in the global ranitidine market include
GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Strides Pharma
Science Limited (StridesShasun), Tocris Bioscience (R & D
Systems), Merck KGaA, and Sun Pharmaceutical Industries Limited among
others.
Detailed
Segmentation:
Global
Ranitidine Market, By Strength:
-
75 mg
-
150 mg
-
300 mg
Global
Ranitidine Market, By Form:
-
Tablet
-
Syrup
-
Injection
Global
Ranitidine Market, By Route of Administration:
-
Oral
-
Intravenous
-
Global Ranitidine Market, By Application:
-
Intestinal & Stomach Ulcers
-
Gastroesophageal Reflux Disease (GERD)
-
Esophagitis
-
Zollinger-Ellison Syndrome
-
Other Application
To
Get Instant Access, Purchase Report Here:
https://www.coherentmarketinsights.com/insight/buy-now/2131
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment